ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "E128: Nerandomilast for Autoimmune ILD (FIBRONEER-ILD)"
Episode Synopsis
Covering a very interesting study this week, which investiaged the PDE4B inhibitor nerandomilast for patients with progressive pulmonary fibrosis (specifically including 325 patients with autoimmune ILD). Would have been yet another ho hum trial if not for the big reveal... have a listen to find out!
Article: https://www.nejm.org/doi/full/10.1056/NEJMoa2503643
Article: https://www.nejm.org/doi/full/10.1056/NEJMoa2503643
More episodes of the podcast The Evidence Based Rheumatology Podcast
E130: Telitacicept for SLE
22/12/2025
E127: TNFs and All That CHF
22/09/2025
E126: Risk Signals, JAKs, and SELECTIVE-ity
08/09/2025
E122: Guidelines for Maybe Diagnosing HLH
17/04/2025
E121: Obinutuzumab in SLE-LN
02/04/2025
E120: Real Life Use of PEXIVAS-Low
06/03/2025
In God we trust